160 related articles for article (PubMed ID: 31299261)
1. Optimization of transdermal deferoxamine leads to enhanced efficacy in healing skin wounds.
Duscher D; Trotsyuk AA; Maan ZN; Kwon SH; Rodrigues M; Engel K; Stern-Buchbinder ZA; Bonham CA; Barrera J; Whittam AJ; Hu MS; Inayathullah M; Rajadas J; Gurtner GC
J Control Release; 2019 Aug; 308():232-239. PubMed ID: 31299261
[TBL] [Abstract][Full Text] [Related]
2. Deferoxamine can prevent pressure ulcers and accelerate healing in aged mice.
Bonham CA; Rodrigues M; Galvez M; Trotsyuk A; Stern-Buchbinder Z; Inayathullah M; Rajadas J; Gurtner GC
Wound Repair Regen; 2018 May; 26(3):300-305. PubMed ID: 30152571
[TBL] [Abstract][Full Text] [Related]
3. Transdermal deferoxamine prevents pressure-induced diabetic ulcers.
Duscher D; Neofytou E; Wong VW; Maan ZN; Rennert RC; Inayathullah M; Januszyk M; Rodrigues M; Malkovskiy AV; Whitmore AJ; Walmsley GG; Galvez MG; Whittam AJ; Brownlee M; Rajadas J; Gurtner GC
Proc Natl Acad Sci U S A; 2015 Jan; 112(1):94-9. PubMed ID: 25535360
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of deferoxamine and hydroxysafflor yellow A to accelerate diabetic wound healing via enhanced angiogenesis.
Gao SQ; Chang C; Li JJ; Li Y; Niu XQ; Zhang DP; Li LJ; Gao JQ
Drug Deliv; 2018 Nov; 25(1):1779-1789. PubMed ID: 30338719
[TBL] [Abstract][Full Text] [Related]
5. Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1α.
Hou Z; Nie C; Si Z; Ma Y
Diabetes Res Clin Pract; 2013 Jul; 101(1):62-71. PubMed ID: 23726275
[TBL] [Abstract][Full Text] [Related]
6. Deferoxamine: An Angiogenic and Antioxidant Molecule for Tissue Regeneration.
Holden P; Nair LS
Tissue Eng Part B Rev; 2019 Dec; 25(6):461-470. PubMed ID: 31184273
[TBL] [Abstract][Full Text] [Related]
7. Transdermal deferoxamine administration improves excisional wound healing in chronically irradiated murine skin.
Lintel H; Abbas DB; Lavin CV; Griffin M; Guo JL; Guardino N; Churukian A; Gurtner GC; Momeni A; Longaker MT; Wan DC
J Transl Med; 2022 Jun; 20(1):274. PubMed ID: 35715816
[TBL] [Abstract][Full Text] [Related]
8. Deferoxamine released from poly(lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis.
Jia P; Chen H; Kang H; Qi J; Zhao P; Jiang M; Guo L; Zhou Q; Qian ND; Zhou HB; Xu YJ; Fan Y; Deng LF
J Biomed Mater Res A; 2016 Oct; 104(10):2515-27. PubMed ID: 27227768
[TBL] [Abstract][Full Text] [Related]
9. Lecithin-based deferoxamine nanoparticles accelerated cutaneous wound healing in diabetic rats.
Qayoom A; Aneesha VA; Anagha S; Dar JA; Kumar P; Kumar D
Eur J Pharmacol; 2019 Sep; 858():172478. PubMed ID: 31228457
[TBL] [Abstract][Full Text] [Related]
10. Iron Chelation with Transdermal Deferoxamine Accelerates Healing of Murine Sickle Cell Ulcers.
Rodrigues M; Bonham CA; Minniti CP; Gupta K; Longaker MT; Gurtner GC
Adv Wound Care (New Rochelle); 2018 Oct; 7(10):323-332. PubMed ID: 30374417
[No Abstract] [Full Text] [Related]
11. Deferoxamine enhances the regenerative potential of diabetic Adipose Derived Stem Cells.
Hopfner U; Maan ZN; Hu MS; Aitzetmüller MM; Zaussinger M; Kirsch M; Machens HG; Duscher D
J Plast Reconstr Aesthet Surg; 2020 Sep; 73(9):1738-1746. PubMed ID: 32418841
[TBL] [Abstract][Full Text] [Related]
12. Bioactive Injectable Hydrogels Containing Desferrioxamine and Bioglass for Diabetic Wound Healing.
Kong L; Wu Z; Zhao H; Cui H; Shen J; Chang J; Li H; He Y
ACS Appl Mater Interfaces; 2018 Sep; 10(36):30103-30114. PubMed ID: 30113159
[TBL] [Abstract][Full Text] [Related]
13. Deferoxamine: potential novel topical therapeutic for chronic wounds.
Tchanque-Fossuo CN; Dahle SE; Buchman SR; Isseroff RR
Br J Dermatol; 2017 Apr; 176(4):1056-1059. PubMed ID: 28418133
[No Abstract] [Full Text] [Related]
14. Targeted Brain Delivery of Rabies Virus Glycoprotein 29-Modified Deferoxamine-Loaded Nanoparticles Reverses Functional Deficits in Parkinsonian Mice.
You L; Wang J; Liu T; Zhang Y; Han X; Wang T; Guo S; Dong T; Xu J; Anderson GJ; Liu Q; Chang YZ; Lou X; Nie G
ACS Nano; 2018 May; 12(5):4123-4139. PubMed ID: 29617109
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Hydroxylase Inhibitor Dimethyloxalylglycine and the Iron Chelator Deferoxamine in Diabetic and Aged Wound Healing.
Duscher D; Januszyk M; Maan ZN; Whittam AJ; Hu MS; Walmsley GG; Dong Y; Khong SM; Longaker MT; Gurtner GC
Plast Reconstr Surg; 2017 Mar; 139(3):695e-706e. PubMed ID: 28234841
[TBL] [Abstract][Full Text] [Related]
16. Deferoxamine modulates cytokines and growth factors to accelerate cutaneous wound healing in diabetic rats.
Ram M; Singh V; Kumawat S; Kumar D; Lingaraju MC; Uttam Singh T; Rahal A; Kumar Tandan S; Kumar D
Eur J Pharmacol; 2015 Oct; 764():9-21. PubMed ID: 26101070
[TBL] [Abstract][Full Text] [Related]
17. Deferoxamine preconditioning to restore impaired HIF-1α-mediated angiogenic mechanisms in adipose-derived stem cells from STZ-induced type 1 diabetic rats.
Mehrabani M; Najafi M; Kamarul T; Mansouri K; Iranpour M; Nematollahi MH; Ghazi-Khansari M; Sharifi AM
Cell Prolif; 2015 Oct; 48(5):532-49. PubMed ID: 26332145
[TBL] [Abstract][Full Text] [Related]
18. Deferoxamine to Minimize Fibrosis During Radiation Therapy.
Tevlin R; Longaker MT; Wan DC
Adv Wound Care (New Rochelle); 2022 Oct; 11(10):548-559. PubMed ID: 34074152
[No Abstract] [Full Text] [Related]
19. An evaluation of carrier agents for desferoxamine, an up-regulator of vascular endothelial growth factor.
Hertzberg BP; Holt JB; Graff RD; Gilbert SR; Dahners LE
J Biomater Appl; 2013 May; 27(8):1046-54. PubMed ID: 22262572
[TBL] [Abstract][Full Text] [Related]
20. Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage.
Farr AC; Xiong MP
Mol Pharm; 2021 Feb; 18(2):593-609. PubMed ID: 32926630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
